Late Epstein-Barr virus infection of a hepatosplenic γδ T-cell lymphoma arising in a kidney transplant recipient

Haematologica

Volumn 85, Issue 3, 2000, Pages 256-262

  Roncella, Silvio ^b   Cutrona, Giovanna ^b   Truini, Mauro ^b   Airoldi, Irma ^b   Pezzolo, Annalisa ^b   Valetto, Angelo ^b   Di Martino, Daniela ^b   Dadati, Patrizia ^b   De Rossi, Anita ^b   Ulivi, Massimo ^b   Fontana, Iris ^b   Nocera, Arcangelo ^b   Valente, Umberto ^b   Ferrarini, Manlio ^b   Pistoia, Vito ^a  

^a G GASLINI INSTITUTE   (Italy)

^b NONE

Author keywords

T cell lymphoma; Epstein Barr virus; Kidney transplant

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; EPSTEIN BARR VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY TRANSPLANTATION; LYMPHOCYTE CLONE; SPLEEN RUPTURE; T CELL LYMPHOMA; VIRUS INFECTION;

ADULT; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD43; ANTIGENS, CD45; CELL LINEAGE; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; KIDNEY TRANSPLANTATION; LIVER NEOPLASMS; LYMPHOMA, T-CELL; MALE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIALOGLYCOPROTEINS; SPLENIC NEOPLASMS;

EID: 0034117844     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Groh V, Porcelli S, Fabbi M, et al. Human lymphocytes bearing T cell receptor γδ are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med 1989; 169:1277-94.
2. Falini B, Flenghi L, Pileri S, et al. Distribution of T cells bearing different forms of the T cell receptor γδ in normal and pathological human tissues. J Immunol 1989; 143:2480-8.
3. Bordessoule D, Gaulard P, Mason DY. Preferential localisation of human lymphocytes bearing gamma delta T cell receptors to the red pulp of the spleen. J Clin Pathol 1990; 43:461-4.
4. Jarry A, Cerf-Bensussan R, Brousse N, Selz F, Guy-Grand D. Subsets of CD3+ (T cell receptor αβ or γδ) and CD3-lymphocytes isolated from normal human gut epithelium display phenotypical features different from their counterparts in peripheral blood. Eur J Immunol 1990; 20:1097-103.
5. Janeway CA Jr, Jones B, Hayday A. Specificity and function of T cells bearing γδ receptors. Immunol Today 1988; 9:73-6.
6. De Libero G. Sentinel function of broadly reactive human γδ T cells, Immunol Today 1997; 18:22-6.
7. Biondi A, Champagne E, Rossi V, et al. T-cell receptor delta gene rearrangement in childhood T-cell acute lymphoblastic leukemia. Blood 1989; 73:2133-8.
8. Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor γδ. Blood 1990; 75:2213-9.
9. Burg G, Dummer R, Wilhelm M, et al. A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med 1991; 325:1078-81.
10. Wong KF, Chan JK, Matutes E, et al. Hepatosplenic γδ T-cell lymphoma. A distinctive aggressive lymhpoma type. Am J Surg Pathol 1995; 19:718-26.
11. Cooke CB, Krenacs L, Stetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic γδ T-cell origin. Blood 1996; 88:4265-74.
12. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Non-hepatosplenic γδ T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998; 91:1723-31.
13. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
14. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323:1767-9.
15. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990; 323:1723-8.
16. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342:1514-6.
17. Knowles DM, Cesarman F, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders. Blood 1995; 85:552-65.
18. Volk HD, Reinke P, Neuhaus K, Fiebig H, von Baher R. Expansion of CD3+4-8-TCR αβ - T lymphocyte population in renal allograft recipients. Transplantation 1989; 47:556-8.
19. Ross CW, Schnitzer B, Sheldon S, Braun DK, Hanson CA. Gamma/delta T-cell post-transplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol 1994; 102:310-5.
20. Kraus MD, Crawford DF, Kaleem Z, Shenoy S, MacArthur CA, Longtine JA. T γδ hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report. Cancer 1998; 82:983-92.
21. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques; a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-80.
22. Ciccone E, Ferrini S, Bottino C, et al. A monoclonal antibody specific for a common determinant of the human T cell receptor γδ directly activates CD3+ WT31-lymphocytes to express their functional program(s). J Exp Med 1988; 168:1-11.
23. Moretta L, Ciccone E, Ferrini S, et al. Molecular and cellular analysis of human T lymphocytes expressing γδ T-cell receptor. Immunol Rev 1991; 120:117-35.
24. Ferrini S, Prigione I, Bottino C, et al. Monoclonal antibodies which react with the T cell receptor γδ recognize different subsets of CD3+WT31-T lymphocytes. Eur J Immunol 1989; 19:57-61.
25. Breit TM, Wolvers-Tettero IL, Hahlen K, van Wering ER, van Dongen JJ. Extensive junctional diversity of γδ T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease. Leukemia 1991; 5:1076-86.
26. Breit T, Wolvers-Tettero IL, Beishuizen A, Verhoeven MA, van Wering ER, van Dongen JJ. Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-δ gene rearrangements in acute lymphoblastic leukemia. Blood 1993; 82:3063-74.
27. Serrano D, Ghiotto F, Roncella S, et al. The patterns of IL2, IFN-γ, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar. Haematologica 1997; 82:542-9.
28. Gattorno M, Facchetti P, Ghiotto F, et al. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype. Clin Exp Immunol 1997; 109:4-11.
29. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71:1234-43.
30. van Gorp J, Doornewaard H, Verdonck LF, Klopping C, Vos PF, vanden Tweel JG. Posttransplant T-cell lymphoma. Report of three cases and a review of the literature. Cancer 1994; 73:3064-72.
31. Roncella S, Ramarli D, Cooper MK, et al. Establishment of an EBV-positive lymphoblastoid cell line that grows as a lymphoma in nude mice and expresses membrane CD2 molecules. Int J Cancer 1990; 45:299-307.
32. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA-1 positive latency in B lymphocytes. J Virol 1992; 66:122-31.
33. Rowe M, Rowe DT, Gregory CD, et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma. EMBO J 1987; 6:2743-51.
34. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47:883-9.
35. Ometto L, Menin C, Masiero S, et al. Molecular profile of Epstein-Barr virus in human immunodeficiency virus type 1-related lymphadenopathies and lymphomas. Blood 1997; 90:313-22.
36. Semenzato G, Agostini C, Ometto L, et al. CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood 1995; 85:2308-14.
37. Nemerow GR, Wolfert R, McNaughton ME, Cooper NR. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 1985; 55:347-51.
38. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature 1995; 373:255-7.
39. Chomarat P, Kjeldsen-Kragh J, Quayle AJ, Natvig JB, Miossec P. Different cytokine production profile of γδ T cell clones: relation to inflammatory arthritis. Eur J Immunol 1994; 24:2087-91.
40. O'Brien RL, Happ MP, Dallas A, Palmer E, Kubo R, Born WK. Stimulation of a major subset of lymphocytes expressing T cell receptor γδ by an antigen derived from Mycobacterium tuberculosis. Cell 1989; 57:667-74.
41. Sciammas R, Johnson RM, Sperling AI, et al. Unique antigen recognition by a herpesvirus-specific TCR-γδ cell. J Immunol 1994; 152:5392-7.
42. Tsuji M, Mombaerts P, Lefrancois L, Nussenzweig RS, Zavala F, Tonegawa S. γδ T cells contribute to immunity against the liver stages of malaria in αβ T-cell-deficient mice. Proc Natl Acad Sci USA 1994; 91:345-9.
43. Bordignon C, Carlo-Stella C, Colombo MP, et al. Cell therapy: achievements and perspectives. Haematologica 1999; 84:1110-49.
44. Tazzari PL, de Totero D, Bolognesi A, et al. An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins. Haematologica 1999; 84:988-95.